Medikinet
ADHD Treatment Overview:
Medikinet is an ADHD treatment drug which contains methylphenidate and is an active CNS stimulant. Medikinet can form part of a comprehensive treatment programme for attention-deficit/hyperactivity disorder (ADHD) and is suitable for prescription to children over 6 years of age when remedial measures alone prove insufficient.
ADHD treatment pharmaceuticals, such as Medikinet, should not be used in isolation, but as part of a comprehensive treatment programme which typically includes psychological, educational and social measures, the aim being to stabilise children with this behavioural syndrome characterized by symptoms which may include chronic history of short attention span, distractibility, emotional lability, impulsivity, moderate to severe hyperactivity, minor neurological signs and abnormal EEG. As yet there is no evidence to suggest that use of Medikinet impairs learning in any way.
Medikinet and Medikinet XL treatment are not indicated in all children with this syndrome and the decision to use these medicinal product must be based on a very thorough assessment of the severity of the child's symptoms.
Medikinet and Medikinet XL treat the patient by having a mild CNS stimulant effect with more prominent effects on mental than on motor activities. Its mode of action is thought to be due to cortical stimulation and possibly to stimulation of the reticular activating system.
For
more information about Flynn Pharma and its other licensed
pharmaceutical products click 'here'
|
